AGTC Treats First Patient of Second Cohort in Phase 1/2 Clinical XLRP Study; Earns $10 Million Enrollment Milestone
Go back to AGTC Treats First Patient of Second Cohort in Phase 1/2 Clinical XLRP Study; Earns $10 Million Enrollment Milestone| APPLIED GEN TECHNLG (NASDAQ: AGTC) | Delayed: 0.39 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.39 | 52 Week High | $21.43 | |||
| Open | $208.89 | 52 Week Low | $6.35 | |||
| Day High | $0.39 | P/E | N/A | |||
| Day Low | $0.39 | EPS | $0.00 | |||
| Volume | 512,976 | |||||
| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 219.07 +3.57 (1.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $215.50 | 52 Week High | $333.65 | |||
| Open | $216.14 | 52 Week Low | $223.02 | |||
| Day High | $221.92 | P/E | 28.05 | |||
| Day Low | $214.59 | EPS | $7.81 | |||
| Volume | 928,562 | |||||
